Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose cytotoxics as anti-angiogenesis treatment after adjuvant chemotherapy for endocrine-nonresponsive breast cancer
2005-005666-36Phase 3Completed
- Sponsor
- International Breast Cancer Study Group
- Start
- Jul 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclophosphamide, methotrexate in breast cancer, sponsored by International Breast Cancer Study Group. Started Jul 2009; status: completed.
02
Drugs
cyclophosphamidemethotrexate
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-005666-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005666-36.